Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Arch Razi Inst ; 75(1): 55-62, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-32292003

RESUMEN

Doxorubicin (DOX) is one of the secondary metabolites of Streptomyces peucetius var. caesius. It is a common and effective chemotherapeutic agent used for the treatment of different diseases, including lymphoma, leukemia, breast cancer, and solid tumors. However, this medicine causes cardiotoxic side effects, which limit its clinical application. The present study examined the cardiomyopathy induced by DOX via echocardiography and transmission electron microscopy (TEM). The main objective was to evaluate the capacity of echocardiography and TEM as diagnostic tools for DOX-induced cardiotoxicity. Moreover, the correlation between intracellular and functional changes due to cardiotoxicity was assessed in a rat model. Cardiomyopathy was induced in rats by two cumulative doses of DOX. Group I received DOX 12 [i.e., 12 mg/kg, intraperitoneal (IP)] and group II received DOX 15 (i.e., 15 mg/kg, IP) in six equal doses over two weeks. Group III as the control (Ctrl) group received normal saline as a vehicle. Mortality during the study was only observed in the DOX 15 group. The echocardiographic assessments revealed significant changes in ejection fraction, fractional shortening, and heart rate in the groups which received DOX. In addition, severe cardiac arrhythmia was evident in DOX-treated groups. Remarkable adverse effects, such as moderately degenerated cells and inflated mitochondria were observed in the TEM analysis of rat hearts in the DOX groups. The present study indicated that rat models are suitable for investigating DOX-induced cardiomyopathy, especially at the dose of 12 mg/kg. Furthermore, echocardiography and TEM examinations were found to be valuable methods for the determination of cardiotoxicity in rats due to DOX.


Asunto(s)
Antibióticos Antineoplásicos , Doxorrubicina , Ecocardiografía , Corazón , Miocardio , Animales , Masculino , Ratas , Antibióticos Antineoplásicos/toxicidad , Cardiotoxicidad , Doxorrubicina/toxicidad , Corazón/efectos de los fármacos , Microscopía Electrónica de Transmisión , Miocardio/patología , Miocardio/ultraestructura , Distribución Aleatoria , Ratas Wistar
2.
Nanoscale ; 7(8): 3768-79, 2015 Feb 28.
Artículo en Inglés | MEDLINE | ID: mdl-25644549

RESUMEN

Effective treatment of ovarian cancer depends upon the early detection of the malignancy. Here, we report on the development of a new nanostructured immunosensor for early detection of cancer antigen 125 (CA-125). A gold electrode was modified with mercaptopropionic acid (MPA), and then consecutively conjugated with silica coated gold nanoparticles (AuNP@SiO2), CdSe quantum dots (QDs) and anti-CA-125 monoclonal antibody (mAb). The engineered MPA|AuNP@SiO2|QD|mAb immunosensor was characterised using transmission electron microscopy (TEM), atomic force microscopy (AFM), cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS). Successive conjugation of AuNP@SiO2, CdSe QD and anti-CA-125 mAb onto the gold electrode resulted in sensitive detection of CA-125 with a limit of detection (LOD) of 0.0016 U mL(-1) and a linear detection range (LDR) of 0-0.1 U mL(-1). Based on the high sensitivity and specificity of the immunosensor, we propose this highly stable and reproducible biosensor for the early detection of CA-125.


Asunto(s)
Biomarcadores de Tumor/sangre , Técnicas Biosensibles , Antígeno Ca-125/sangre , Proteínas de la Membrana/sangre , Neoplasias Ováricas/sangre , Aminas/química , Compuestos de Cadmio , Espectroscopía Dieléctrica , Femenino , Oro/química , Humanos , Límite de Detección , Nanopartículas del Metal , Microscopía de Fuerza Atómica , Microscopía Electrónica de Transmisión , Nanotecnología , Propionatos/química , Compuestos de Selenio , Dióxido de Silicio/química
3.
Pak J Biol Sci ; 11(20): 2443-6, 2008 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-19137857

RESUMEN

The aim of this study was to determine the resistance pattern and the type of resistance genes of vancomycin-resistant Enterococcus faecalis from Gharamalek wastewater treatment plant in Tabriz, Iran. Following filtering of sewage samples, approximately 300 colonies grew on specific media, of which 53 were randomly selected and purified using 0.45 microm membranes. The membranes were placed on culture media containing antibiotics to isolate the vancomycin-resistant Enterococcus. Biochemical tests, antibiogram and determining minimum inhibitory concentration of antibiotics with E-test including vancomycin were performed. Polymerase Chain Reaction (PCR) was carried out to determine the type of resistance genes. All tested samples were found to be E. faecalis. Antimicrobial susceptibility tests indicated multidrug resistance in the samples, with 98% of them highly resistant to vancomycin. The highest frequency was of vanA (96%), followed by vanB (4%); vanC was not seen among the tested samples. The results confirmed that the risk of exposure to antibiotic-resistant pathogens from the evaluated urban wastewater is considerable.


Asunto(s)
Enterococcus faecalis/efectos de los fármacos , Enterococcus faecalis/aislamiento & purificación , Resistencia a la Vancomicina , Microbiología del Agua , Proteínas Bacterianas/genética , Ligasas de Carbono-Oxígeno/genética , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/transmisión , Enterococcus faecalis/genética , Genes Bacterianos , Infecciones por Bacterias Grampositivas/tratamiento farmacológico , Infecciones por Bacterias Grampositivas/transmisión , Humanos , Irán , Reacción en Cadena de la Polimerasa , Resistencia a la Vancomicina/genética , Eliminación de Residuos Líquidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...